Bortezomib Terminated Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00200382Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
NCT00283634A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer